NGM Biopharmaceuticals News and Activities

NGM Biopharmaceuticals is a company listed under the stock ticker NGM (US).

View the org chart displaying its 40 main executives

Most searched biographies at NGM Biopharmaceuticals

• Diana Peng Bockus, Chief Executive Officer
• Shelly Guyer, Director
• William Rieflin, Chairman of the Board

Create your alert
to follow the executive moves at NGM Biopharmaceuticals.

NGM Biopharmaceuticals has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by NGM Biopharmaceuticals

• NGM Bio Appoints Siobhan Nolan Mangini to President and Chief Financial Officer | NGM Biopharmaceuticals, Inc.
• NGM Bio to Host the Final of Four Virtual R&D Events on June 29, 2022 | NGM Biopharmaceuticals, Inc.
• NGM Bio to Participate in Upcoming Investor Conferences | NGM Biopharmaceuticals, Inc.
• NGM Bio to Host the Third of Four Virtual R&D Events on May 31, 2022 | NGM Biopharmaceuticals, Inc.
• NGM Bio Announces Initiation of Phase 1/1b Clinical Study of NGM438 for the Treatment of Patients with Advanced Solid Tumors | NGM Biopharmaceuticals, Inc.
• NGM Bio Provides Business Highlights and Reports First Quarter 2022 Financial Results | NGM Biopharmaceuticals, Inc.
• News | NGM Biopharmaceuticals, Inc.
• News | NGM Biopharmaceuticals, Inc.
• NGM Bio to Participate in Upcoming Investor Conferences | NGM Biopharmaceuticals, Inc.
• NGM Bio to Host the Second of Four Virtual R&D Events on April 27, 2022 | NGM Biopharmaceuticals, Inc.
• View more press releases Close

Social media about NGM Biopharmaceuticals

• NGM Biopharmaceuticals on Wikipedia, Google News & Yahoo Finance
• NGM Biopharmaceuticals on LinkedIn, X (Twitter) & YouTube